Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF maintenance in advanced malignant pleural mesothelioma
NCT01358084Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Mar 2011
- Primary completion
- Dec 2018
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of NGR-TNF in malignant pleural mesothelioma (MPM), sponsored by AGC Biologics. Started Mar 2011; status: completed.
02
Drugs
NGR-TNF
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01358084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358084.